Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2019, 163(3):259-264

MicroRNA-210 expression during childbirth and postpartum as a potential biomarker of acute fetal hypoxia

Barbara Vonkovaa,b,d, Ivona Blahakovaa,b, Lukas Hrubanc, Petr Jankuc, Sarka Pospisilovaa,b
a Center of Molecular Medicine, CEITEC - Central European Institute of Technology, Masaryk University, Brno, Czech Republic
b Center of Molecular Biology and Gene Therapy, Department of Internal Medicine - Hematology and Oncology, University Hospital Brno, Czech Republic
c Department of Gynaecology and Obstetrics, The University Hospital Brno, Czech Republic
d Faculty of Medicine, Masaryk University, Brno, Czech Republic

Objective: To explore whether miR-210 expression can be used as a diagnostic and prognostic marker in acute fetal hypoxia.

Methods: Whole blood samples of 29 women and their fetuses without hypoxia and 24 women and their fetuses with hypoxia were analysed in this study. Reverse transcription and quantitative real-time PCR were used to measure the expression of miR-210. Expression level differences between the control and hypoxic group in labour time and postpartum change fold were analyzed by standard statistical tests.

Results: We confirmed that miR-210 is significantly more upregulated in fetal blood with acute hypoxia when compared to maternal blood (P Conclusions: Our study confirmed miR-210 upregulation in the blood of pregnant women with acute fetal hypoxia at the time of labour compared to pregnant women without acute fetal hypoxia. Additional investigation should be done to determine miR-210 clearance and the possibility of using miR-210 as a diagnostic and prognostic marker.

Keywords: microRNA-210, acute fetal hypoxia, postpartum, clearance of miR-210

Received: April 20, 2018; Revised: October 10, 2018; Accepted: December 4, 2018; Prepublished online: December 18, 2018; Published: September 23, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vonkova, B., Blahakova, I., Hruban, L., Janku, P., & Pospisilova, S. (2019). MicroRNA-210 expression during childbirth and postpartum as a potential biomarker of acute fetal hypoxia. Biomedical papers, 163(3), 259-264
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Alfirevic Z, Devane D, Gyte GM, Cuthbert A. Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour. Cochrane Database Syst Rev 2007;2:CD006066. Go to original source... Go to PubMed...
    2. Heintz E, Brodtkorb TH, Nelson N, Levin LA. The long-term cost-effectiveness of fetal monitoring during labour: a comparison of cardiotocography complemented with ST analysis versus cardiotocography alone. BJOG Int J Obstet Gynaecol 2008;115:1676-87. Go to original source... Go to PubMed...
    3. Strachan BK, van Wijngaarden WJ, Sahota D, Chang A, James DK. Cardiotocography only versus cardiotocography plus PR-interval analysis in intrapartum surveillance: a randomised, multicentre trial. FECG Study Group. Lancet Lond Engl 2000;355:456-9. Go to original source... Go to PubMed...
    4. d'Aloja E, Müller M, Paribello F, Demontis R, Faa A. Neonatal asphyxia and forensic medicine. J Matern Fetal Neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet 2009;22(Suppl 3):54-6. Go to original source... Go to PubMed...
    5. Visser GH, Ayres-de-Campos D and FIGO Intrapartum Fetal Monitoring Expert Consensus Panel. FIGO consensus guidelines on intrapartum fetal monitoring: Adjunctive technologies. Int J Gynaecol Obstet Off Organ Int Fed Gynaecol Obstet 2015;131:25-9. Go to original source... Go to PubMed...
    6. Steer PJ. Has electronic fetal heart rate monitoring made a difference. Semin Fetal Neonatal Med 2008;13:2-7. Go to original source... Go to PubMed...
    7. Blackwell SC, Grobman WA, Antoniewicz L, Hutchinson M, Gyamfi Bannerman C. Interobserver and intraobserver reliability of the NICHD 3-Tier Fetal Heart Rate Interpretation System Am J Obstet Gynecol 2011;205:378.e1-5. Go to original source... Go to PubMed...
    8. Ayres-de-Campos D, Bernardes J, FIGO Subcommittee. Twenty-five years after the FIGO guidelines for the use of fetal monitoring: time for a simplified approach? Int J Gynaecol Obstet Off Organ Int Fed Gynaecol Obstet 2010;110:1-6. Go to original source... Go to PubMed...
    9. Hruban L, Spilka J, Chudáček V, Janků P, Huptych M, Burša M, Hudec A, Kacerovský M, Koucký M, Procházka M, Korečko V, Seget'a J, Šimetka O, Měchurová A, Lhotská L. Agreement on intrapartum cardiotocogram recordings between expert obstetricians. J Eval Clin Pract 2015;21:694-702. Go to original source... Go to PubMed...
    10. Schifrin BS, Cohen WR. The effect of malpractice claims on the use of caesarean section. Best Pract Res Clin Obstet Gynaecol 2013;27:269-83. Go to original source... Go to PubMed...
    11. Cohen WR, Schifrin BS. Medical negligence lawsuits relating to labor and delivery. Clin Perinatol 2007;34:345-60. Go to original source... Go to PubMed...
    12. Siggaard-Andersen O, Huch R. The oxygen status of fetal blood. Acta Anaesthesiol Scand 1995;Suppl 107:129-35. Go to original source... Go to PubMed...
    13. Corn PG. Hypoxic regulation of miR-210: shrinking targets expand HIF-1's influence. Cancer Biol Ther 2008;7:265-7. Go to original source... Go to PubMed...
    14. Wang H, Flach H, Onizawa M, Wei L, McManus MT, Weiss A. Negative regulation of Hif1a expression and TH17 differentiation by the hypoxia-regulated microRNA miR-210. Nat Immunol 2014;15:393-401. Go to original source... Go to PubMed...
    15. Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, Yerushalmi N, Benjamin H, Kushnir M, Cholakh H, Melamed N, Bentwich Z, Hod M, Goren Y, Chajut A. Serum microRNAs are promising novel biomarkers. PLoS One 2008;3:e3148. Go to original source... Go to PubMed...
    16. Luo S, Ishibashi O, Ishikawa G, Ishikawa T, Katayama A, Mishima T, Takizawa T, Shigihara T, Goto T, Izumi A, Ohkuchi A, Matsubara S, Takeshita T, Takizawa T. Human villous trophoblasts express and secrete placenta-specific microRNAs into maternal circulation via exosomes. Biol Reprod 2009;81:717-29. Go to original source... Go to PubMed...
    17. Chan YC, Banerjee J, Choi SY, Sen CK. miR-210: the master hypoxamir. Microcirculation 2012;19:215-23. Go to original source... Go to PubMed...
    18. Chan SY, Loscalzo J. MicroRNA-210: a unique and pleiotropic hypoxamir. Cell Cycle Georget Tex 2010;9:1072-83. Go to original source... Go to PubMed...
    19. Whitehead CL, Teh WT, Walker SP, Leung C, Larmour L, Tong S. Circulating MicroRNAs in maternal blood as potential biomarkers for fetal hypoxia in-utero. PLoS One 2013;8:e78487. Go to original source... Go to PubMed...
    20. Flenady V, Koopmans L, Middleton P, Frøen JF, Smith GC, Gibbons K, Coory M, Gordon A, Ellwood D, McIntyre HD, Fretts R, Ezzati M. Major risk factors for stillbirth in high-income countries: a systematic review and meta-analysis. Lancet 2011;377:1331-40. Go to original source... Go to PubMed...
    21. Baggish AL, Hale A, Weiner RB, Lewis GD, Systrom D, Wang F, Wang TJ, Chan SY. Dynamic regulation of circulating microRNA during acute exhaustive exercise and sustained aerobic exercise training. J Physiol 2011;589:3983-94. Go to original source... Go to PubMed...
    22. Jamali Z, Asl Aminabadi N, Attaran R, Pournagiazar F, Ghertasi Oskouei S, Ahmadpour F. MicroRNAs as prognostic molecular signatures in human head and neck squamous cell carcinoma: a systematic review and meta-analysis. Oral Oncol 2015;51:321-31. Go to original source... Go to PubMed...
    23. Li G, Zhao A, Péoch M, Cottier M, Mottet N. Detection of urinary cell-free miR-210 as a potential tool of liquid biopsy for clear cell renal cell carcinoma. Urol Oncol 2017;35(5):294-9. Go to original source... Go to PubMed...
    24. Yang W, Ma J, Zhou W, Zhou X, Cao B, Fan D, Hong L. Biological implications and clinical value of mir-210 in gastrointestinal cancer. Expert Rev Gastroenterol Hepatol 2017;1-10. Go to original source... Go to PubMed...
    25. Zhu W, Zhou K, Zha Y, Chen D, He J, Ma H, Liu X1, Le H, Zhang Y. Diagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer. PLoS One 2016;11:e0153046. Go to original source... Go to PubMed...
    26. Lycoudi A, Mavreli D, Mavrou A, Papantoniou N, Kolialexi A. miRNAs in pregnancy-related complications. Expert Rev Mol Diagn 2015;15:999-1010. Go to original source... Go to PubMed...
    27. Munaut C, Tebache L, Blacher S, Noël A, Nisolle M, Chantraine F. Dysregulated circulating miRNAs in preeclampsia. Biomed Rep 2016;5:686-92. Go to original source... Go to PubMed...
    28. Chim S, Shing TK, Hung EC, Leung TY, Lau TK, Chiu RW, Lo YM. Detection and characterization of placental microRNAs in maternal plasma. Clin Chem 2008;54:482-90. Go to original source... Go to PubMed...
    29. Morisaki S, Miura K, Higashijima A, Abe S, Miura S, Hasegawa Y, Yoshida A, Kaneuchi M, Yoshiura K, Masuzaki H. Effect of labor on plasma concentrations and postpartum clearance of cell-free, pregnancy-associated, placenta-specific microRNAs. Prenat Diagn 2015;35:44-50. Go to original source... Go to PubMed...
    30. Reddy A, Zhong XY, Rusterholz C, Hahn S, Holzgreve W, Redman CW, Sargent IL. The effect of labour and placental separation on the shedding of syncytiotrophoblast microparticles, cell-free DNA and mRNA in normal pregnancy and pre-eclampsia. Placenta 2008;29:942-9. Go to original source... Go to PubMed...
    31. Fasanaro P, D'Alessandra Y, Di Stefano V, Melchionna R, Romani S, Pompilio G, Capogrossi MC, Martelli F. MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. J Biol Chem 2008;283:15878-83. Go to original source... Go to PubMed...
    32. Hunter MP, Ismail N, Zhang X, Aguda BD, Lee EJ, Yu L, Xiao T, Schafer J, Lee ML, Schmittgen TD, Nana-Sinkam SP, Jarjoura D, Marsh CB. Detection of microRNA expression in human peripheral blood microvesicles. PloS One 2008;3:e3694. Go to original source... Go to PubMed...
    33. Vickers KC, Palmisano BT, Shoucri BM, Shamburek RD, Remaley AT. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol 2011;13:423-33. Go to original source... Go to PubMed...
    34. Mouillet JF, Chu T, Hubel CA, Nelson DM, Parks WT, Sadovsky Y. The levels of hypoxia-regulated microRNAs in plasma of pregnant women with fetal growth restriction. Placenta 2010; 31:781-4. Go to original source... Go to PubMed...
    35. Wong L, Lee K, Russell I, Chen C. Endogenous Controls for Real-Time Quantitation of miRNA Using TaqMan MicroRNA Assays. Applied Biosystems Application Note 2010;127:AP11-01.
    36. Mouillet JF, Chu T, Sadovsky Y. Expression patterns of placental microRNAs. Birth Defects Res Clin Mol Teratol 2011;91:737-43. Go to original source... Go to PubMed...
    37. Muralimanoharan S, Guo C, Myatt L, Maloyan A. Sexual dimorphism in miR-210 expression and mitochondrial dysfunction in the placenta with maternal obesity. Int J Obes 2015;39:1274-81. Go to original source... Go to PubMed...

    This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content